Table 2.
Primer pair |
Forward |
Reverse |
---|---|---|
Kanamycin* |
CGATTTATTCAACAAAGCCACGTTGTGTCT |
GCCAGTGTTACAACCAATTAACCAATTCTGA |
Δ1-6 |
gtgtcacgcgcacgtgttagcataggaatccagacgcgcgctcgcctgag |
atttacatactcaggacaggtgtgggcggttccaggtgtacgtaagcaga |
Δ6-12 |
acacgcccaaaatcacgcaatcatatataaatggacaatgaagccaatct |
gttctaagtaaaaggggatacgggcgggcgatacagatgtacgaacccaa |
Δ12-18 |
caacaaataaaaattgtacgctcattttatcgcgtctctgtcatgtgttc |
gaggggttggtacggttcgagcgattttggtagtccgagacgtccgccgc |
Δ18-22 |
ttgaatacgattgtttttattggcagcactgagcacacgtcccccccacc |
atccgctcgaggccatgctcaccaagaagaccgagtgtcccaacaacttc |
Δ1-22 |
gtgtcacgcgcacgtgttagcataggaatccagacgcgcgctcgcctgag |
atccgctcgaggccatgctcaccaagaagaccgagtgtcccaacaacttc |
Δ12 |
caacaaataaaaattgtacgctcattttatcgcgtctctgtcatgtgttc |
gttctaagtaaaaggggatacgggcgggcgatacagatgtacgaacccaa |
Δ13 |
tagaacaatatgtaaaccatctctcattcagctacatacagacaagggac |
Tgataagaattatactttaatgggggacacgttctagaacacgataaact |
Δ14 |
Agtataattcttatcaattataccagagtttggtatttttttaatctgag |
Cgagtgtgaaatggggaaactggcgcgtcttttcattcgtgctccacagc |
Δ15/16 |
cactcgctatccttcgaccacactttcgagtcttttaccgtatcaagaag |
Acaataaagatttcagacaaaaagtatggattgtgtgataatttattaaa |
Δ17 |
catactttttgtctgaaatctttattgtacgccatcgaaataaggggagc |
gtctgctttctttgaaatcggacgaccgatcagaacgtccgccttcgaga |
∆18 |
ttgaatacgattgtttttattggcagcactgagcacacgtcccccccacc |
Gaggggttggtacggttcgagcgattttggtagtccgagacgtccgccgc |
∆19 |
ccaagacgctcgtcttataacaccgactgacgtttactccgactcaggat |
Tcgaggcgagtcttcggagctgtacgctagggcgatcgccatcaccctct |
∆20/21 |
Cggcgacgacggcgatcacggcgagggtgaagagggtgatggcgatcgcc |
Gctgtcatgtaaatggacggttattaaaagatgaggtcgtgtgacctctg |
∆22 |
Gggtagcgcctcgatcgacgagcgtcggacaaagaaaccgggagaagaag |
Atccgctcgaggccatgctcaccaagaagaccgagtgtcccaacaacttc |
MCMVm18stop |
gcagcggttccgccgtccccatcgcgacgatgggcgctccgaattcctaataaaccgactcccgtccccaccaaggatgacgacgataagtaggg |
ggagcgcccatcgtcgcgatttattaggaattccgcgctgctggcgatgagcgtggtggggacgggagtcggtaaccaattaaccaattctgattag |
*Kanamycin specific oligos were added to the 3 the 3ggaattccgcgctgctggcgatgagcgtggtgggga.